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Background: Improving the quality and safety of perioperative care is a global priority. The Enhanced Peri-Operative
Care for High-risk patients (EPOCH) trial was a stepped-wedge cluster randomised trial of a quality improvement (QI)
programme to improve 90-day survival for patients undergoing emergency abdominal surgery in 93 hospitals in the
UK National Health Service.
Methods: The aim of this process evaluation is to describe how the EPOCH intervention was planned, delivered and
received, at both cluster and local hospital levels. The QI programme comprised of two interventions: a care pathway
and a QI intervention to aid pathway implementation, focussed on stakeholder engagement, QI teamwork, data
analysis and feedback and applying the model for improvement. Face-to-face training and online resources were
provided to support senior clinicians in each hospital (QI leads) to lead improvement. For this evaluation, we collated
programme activity data, administered an exit questionnaire to QI leads and collected ethnographic data in six
hospitals. Qualitative data were analysed with thematic or comparative analysis; quantitative data were analysed using
descriptive statistics.
Results: The EPOCH trial did not demonstrate any improvement in survival or length of hospital stay. Whilst the QI
programme was delivered as planned at the cluster level, self-assessed intervention fidelity at the hospital level was
variable. Seventy-seven of 93 hospitals responded to the exit questionnaire (60 from a single QI lead response
on behalf of the team); 33 respondents described following the QI intervention closely (35%) and there were
only 11 of 37 care pathway processes that > 50% of respondents reported attempting to improve. Analysis of
qualitative data suggests QI leads were often attempting to deliver the intervention in challenging contexts:
the social aspects of change such as engaging colleagues were identified as important but often difficult and
clinicians frequently attempted to lead change with limited time or organisational resources.
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Conclusions: Significant organisational challenges faced by QI leads shaped their choice of pathway components to
focus on and implementation approaches taken. Adaptation causing loss of intervention fidelity was therefore due to
rational choices made by those implementing change within constrained contexts. Future large-scale QI programmes
will need to focus on dedicating local time and resources to improvement as well as on training to develop QI
capabilities.
EPOCH trial registration: ISRCTN80682973 https://doi.org/10.1186/ISRCTN80682973 Registered 27 February 2014 and
Lancet protocol 13PRT/7655.
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There is widespread recognition of the need to improve
the quality and safety of peri-operative care globally [1,
2]. Data demonstrate both the volume of adverse events
and complications related to surgery, and the need to
focus on high-risk patients who suffer disproportionate
morbidity and mortality [3–6]. Our group led a major
trial to assess the clinical effectiveness of a quality im-
provement programme on outcomes for patients under-
going emergency abdominal surgery, also known as
emergency laparotomy [7]. Emergency laparotomy is a
commonly performed surgical procedure, with a high
30-day mortality [8–11] and wide variations in the stan-
dards of care delivered [10–12]. Previous small studies
of quality improvement in this area have improved care
delivery and reduced mortality without increasing costs
[10, 13, 14]. The EPOCH trial was designed to establish
whether a quality improvement approach could reduce
mortality and length of hospital stay for this patient
group, when delivered at a national level. The trial was
performed against the backdrop of a national focus in
the UK on emergency laparotomy and the launch of the
National Emergency Laparotomy Audit (NELA) which
began patient data collection 4 months before the start
of trial recruitment [15].
Quality improvement programmes can be seen has hav-
ing a ‘hard core’, the clinical processes or practices that are
the focus of improvement, and a ‘soft periphery’, the im-
provement methods that will enable change to occur [16].
In the EPOCH trial, the ‘hard core’ was a set of recom-
mended clinical processes, organised within a care path-
way for patients undergoing emergency laparotomy. The
EPOCH trial care pathway was developed through an
evidence-based Delphi consensus process to update exist-
ing guidelines published by the Royal College of Surgeons
of England [17]. Details of the 37 component interven-
tions are provided in Fig. 1, and a full summary of
evidence grading is available on the trial website (www.e-
pochtrial.org). The quality improvement intervention (the
‘soft periphery’) was designed to enable the QI leads and
their teams to effectively improve the care pathway forpatients undergoing emergency laparotomy. Two clini-
cians with quality improvement and training expertise (TS
and CP) developed the programme theory (describing ‘the
how’ and ‘the why’ of the QI intervention; see Tables 1
and 2) based on current evidence and learning from other
quality improvement programmes [13, 18–20]. Quality
improvement (QI) interventions, such as those delivered
within the EPOCH trial, are complex due to their interact-
ing components and the multiple organisational and social
levels at which change must be effected [21, 22]. Deliver-
ing a complex intervention into a complex system, such as
the perioperative care pathway in a hospital, is challenging
with many possible barriers to achieving intended out-
comes. Even within a trial setting, this complexity may
mean that the target group is not actually exposed to the
planned interventions [21, 23]. Therefore, in addition to
the main trial, we conducted a process evaluation, with
the aim of providing greater understanding of the com-
plexity inherent in large-scale improvement programmes
such as the EPOCH trial.
In this paper, we describe how one of the largest trials of
a quality improvement intervention to date was planned,
delivered and received across 93 hospitals that offer emer-
gency abdominal surgery within the United Kingdom’s
(UK) National Health Service (NHS), [15] and provide de-
tailed analysis to facilitate a greater understanding of the
main trial results.
Methods
Process evaluation
We undertook a mixed-methods process evaluation with
both prospective and retrospective components, based
upon recommended guidance for evaluation of cluster
trials [21, 24]. All components of the evaluation were
performed without knowledge of the trial results, either
by participants or evaluators.
Overview of the EPOCH trial
The EPOCH trial was a stepped-wedge cluster rando-
mised trial across 93 UK National Health Service (NHS)
hospitals. Patients were recruited from March 2014 to
Fig. 1 The EPOCH trial recommended care pathway. Legend: SIRS, systemic inflammatory response syndrome; Sepsis Six, a protocolised treatment for
sepsis; CT, computer-aided tomography; WHO, World Health Organization; ABG, arterial blood gas; NMB, Neuro-muscular blockade; CCOT, critical care
outreach team; NEWS, National Early Warning Score; VTE, venous thrombo-embolism
Table 1 Summary of the EPOCH trial programme theory
If
- Relevant data are reviewed and fed back to teams regularly,
- Key professionals come together to form an improvement team,
- QI leads and colleagues learn basic quality improvement
approaches, and
- Relevant stakeholders are made aware of the project and
improvement goals
Then
- A shared view of performance and improvement gaps can be
created,
- Professionals can work as a team to define and achieve local
improvement goals,
- Basic quality improvement approaches can be employed to achieve
the improvement goals, and
- Stakeholders will be more engaged in the need for change and
aware of how improvement will occur
So that
- Improvements in care delivery in line with the recommended care
pathway can be achieved
So that
- Mortality after emergency laparotomy can be reduced.
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clusters of six to eight geographically co-located hospitals.
Data for the trial were obtained via the National Emer-
gency Laparotomy Audit (NELA), funded separately by
the UK Healthcare Quality Improvement Programme [15]
which started collecting data on 1 December 2013. Each
recruited hospital nominated three senior clinicians (con-
sultants) to act as quality improvement leads (QI leads)
from key clinical areas (surgery, anaesthesia and critical
care) and confirmed NHS Trust executive board support.
Improvement skills or previous improvement experience
were not pre-requisites to be a QI lead. No QI leads re-
ceived funded time to undertake the improvement work
nor to attend study meetings. The EPOCH trial was ap-
proved by the Research Ethics Committee of the National
Health Service (REC reference 13/EM/0415).
Six QI strategies were recommended to support path-
way implementation: (1) stakeholder engagement, (2)
building a QI team, (3) analysing local data collected for
NELA, (4) using run-charts to inform progress and feed-
back to colleagues, (5) segmenting the patient pathway to
make change more manageable, and (6) use of Plan-Do-
Study-Act (PDSA) cycles to support the change process.
The QI programme provided guidance on how to use the
six QI strategies to implement the pathway; each cluster
received an introductory day of QI training (at the cluster
activation meeting), a follow-up half-day meeting and
Table 2 The EPOCH trial Quality Improvement (QI) programme theory
Desired outcomes QI strategies QuIP activities and
resources
Evidence for inclusion within programme
theory
Motivation for change
created amongst stakeholders
and improvement goals clearly
understood
QI leads hold a stakeholder meeting
after activation
(QI strategy 1)
1. Pre-activation checklist
(providing guidance for
planning of stakeholder
meeting)
2. Evidence for QI and
need for change provided
3. Presentation on achieving
engagement
• Improvement projects require attention
to the social context in which
improvements are to be made which
in turn requires relevant stakeholders to
be informed and engaged (e.g.
evidence from both Michigan Keystone
and Enhanced Recovery programmes
[19, 48])
• Data feedback can create cognitive
dissonance if it is at variance from
self-assessed or perceived performance,
which in turn can lead to motivation for
change [49].
Inter-professional
collaboration (IPC)
fostered
Each hospital to form an inter-
professional improvement team
(QI strategy 2)
4. Team approach
promoted
5. QI leads encouraged to
invite colleague to EPOCH
meetings
6. EPOCH VLE open to all
local QI team members
• There is sound theoretical and empirical
evidence for the specific role of
clinically-led quality improvement teams
in successful QI [42, 50].
Shared view of current
performance created
(‘situational awareness’)
QI leads analyse their own data (NELA
data +/− case note reviews and local
audit data) and feed this back to
colleagues regularly
(QI strategy 3)
7. Case-note review tool
8. Training on data for
improvement
9. Training on how to access
and analyse NELA data
10. Excel workbook
programmed to create run
charts from NELA data
11. Secure data sharing
site created on VLE
• Creating situational awareness
regarding clinical performance is seen
as fundamental to The Model for
Improvement [51] and is the foundation
of Feedback Intervention Theory
[49, 52]
• Recent empirical data points to data
feedback as central to success of several
key QI projects [13, 19, 53]
• Cochrane reviews on data feedback
indicate a positive impact on quality
improvement if feedback is appropriate
and timely and when a path to improvement
is proposed [35, 52].
Frontline teams develop
and use basic QI skills to
effect change
QI leads and other team members:
Use time-series charts (‘run-charts’)
(QI strategy 4)
Segment the patient pathway
(Qi strategy 5)
Use the Plan-Do-Study-Act (PDSA)
cycles
(QI strategy 6)
12. Introduction to QI skills
training provided
13. Links to further reading
and training resources for QI
14. Telephone and email
support
• Application of improvement science
approaches such as the Model for
Improvement require at least some basic skill
acquisition, and evidence points to a deficit
in this area putting significant strain on the
ability of an improvement project to achieve
its potential [38, 54].
• Time-series charts (‘run-charts’) are a simple
and robust method of analysing and
presenting (for data feedback) changes to
care processes [55].
• Segmentation of the proposed patient
pathway involves introducing interventions
within the pathway in an iterative fashion.
Pathway segmentation makes the clinical
element of this intervention less complex,
more compatible with current systems and
may makes process changes more trial-able
and lower risk [34]
• The IHI’s Model for Improvement, incl. The
PDSA cycle, is an internationally accepted
approach to quality improvement [51, 56].
QuIP Quality Improvement Programme, VLE Virtual Learning Environment, NELA National Emergency Laparotomy Audit)
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plus access to web-based resources designed for the
programme. Nominated QI leads were encouraged to in-
vite colleagues from their sites to join them at these meet-
ings. To further create a collaborative environment forhospitals to share learning, two additional national meet-
ings were convened which teams in activated sites could
attend [see Additional file 1 for full programme details].
The QI intervention was designed to be ‘light touch’,
recognising the limited resources of the study, of clinician
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through NELA was already occurring. All sites received a
small payment (£3700) to support local QI efforts, and on-
going QI advice was available by telephone or email from
the programme leads (TS and CP).
Data sources and data collection
Table 3 details the evaluation foci and the three data
sources used to investigate these: (1) routine QI
programme activity data (records of meeting attendance
and use of the web-based resources), (2) data from an
exit questionnaire sent to all QI leads and (3) ethno-
graphic data. The 37-item, online questionnaire, admin-
istered at the end of the study period, was designed to
allow QI leads to describe activities undertaken as well
as their overall experience of leading the improvement
projects. This provided information on fidelity to the
intended intervention and what helped and hindered
progress. The questionnaire included categorical yes/no
answers and space for comments (see Additional file 1
for a full list of questions). The questionnaire was de-
signed and piloted in line with best practice, with two
rounds of testing using research team members, for
readability and usability and a final round of testing
using eight QI leads [25, 26]. Changes from this final
round were very minor, and therefore, responses from
this sample were included in the analysis. Only one
response was required per hospital, but QI leads were
asked to complete the questionnaire with colleagues. A
pre-planned ethnographic evaluation was undertaken in
six trial sites by researchers outside the main EPOCH
team (GM, DK). A maximum variation sample of sites
was chosen, with criteria focussed on size of the hospital,Table 3 Data collected for process evaluation
Aspect of process
evaluation
Data collection method Data co
Delivery to the
clusters
1. Collation of registers from QuIP meetings
(30 meetings in total across 93 hospitals)
2. Collation of VLE usage logs
1. The n
meetin
2. The l
determ
each ho
Response of the
clusters
1. Online exit questionnaire
2. Ethnographic data
1. Free-
program
2. Obse
Delivery at the site
level – QI
intervention
1. Online exit questionnaire 1. Whet
2. Whet
team (Q
3. Whet
4. Whet
5. Whet
6. Whet
Response of the sites/
individuals
1. Online exit questionnaire
2. Ethnographic data
1. Free-
If you w
doing’
2. Obse
QuIP Quality Improvement Programme, VLE Virtual Learning Environment, NELA Natsurgical volume and discipline of the QI lead. Periods of
observation were scheduled, and interviews with clini-
cians were held at several points during the trial to moni-
tor progress and reflect on what had been achieved and
what had impeded progress. All interviews were audio re-
corded, and field notes recorded in a diary at the time of
observation, or immediately afterwards. Further details of
the ethnographic methods are reported elsewhere [27].
Data analysis
The programme activity and questionnaire data were
analysed and reported using descriptive statistics (fre-
quency (%) for categorical data or median (range) for
continuous data). Answers to three free-text questions
within the questionnaire, designed to stimulate reflec-
tion on participation in the QI programme and on
leading quality improvement locally, were analysed
using deductive and inductive content analysis [28].
Data were initially managed in Microsoft Excel and
coded manually. Two authors (TS and TA) independ-
ently generated codes and categories emerging from
these data inductively. These were compared and re-
fined through rounds of discussion and sense-making.
A set of overarching sub-themes was agreed and used
these as a framework for further, more deductive, cod-
ing. Finally, these sub-themes were grouped into high-
level themes for each question [28, 29]. Themes were dis-
cussed with the EPOCH ethnographic team in order to
enhance validity and to support the analysis and emerging
conclusions; this occurred after analysis of the ethno-
graphic data had been completed but prior to findings be-
ing reported to the main trial team. Data analysis for the
ethnographic data was based on the constant comparativellected and data type
ames, roles and hospital of each of the attendees at the QuIP cluster
gs (2 meetings per cluster)
evel of usage of the Virtual Learning Environment (VLE) per hospital,
ined by the number of visits/views logged by any staff member from
spital
text responses regarding the positive and negative aspects of the
me
rvations and interviews with key staff in the 6 ethnographic sites
her a stakeholder meeting was held (QI strategy 1)
her a QI team was formed and professional composition of any such
I strategy 2)
her and how data feedback occurred (QI strategy 3)
her run-charts were used (QI strategy 4)
her the patient pathway was segmented (QI strategy 5)
her the PDSA approach was used (QI strategy 6)
text responses to 2 reflective questions:
ere to be involved in EPOCH again, (a) ‘what would you continue
and (b) ‘what would you do differently’?
rvations and interviews with key staff in the 6 ethnographic sites
ional Emergency Laparotomy Audit
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the literature (for example, the role of context on QI pro-
jects) and discussions within the EPOCH team. Data from
different sources, as outlined in Table 3, were analysed
separately and then integrated to meet the evaluation aims
for this paper. Data analysis from the questionnaire pro-
vided a cohort-wide picture of response to the programme
and of intervention delivery at site level, with ethno-
graphic data analysis adding granular detail and under-
standing. Integration was achieved through discussion
amongst the authors responsible for analysis of the differ-
ent components, identifying points of confluence and
apparent contradiction between the data, and particularly
focusing on the ways in which insights derived from the
ethnographic work might explain or add detail to findings
from the survey.
Results
Effectiveness and main trial outcomes
The main trial primary outcome measure was 90-day
mortality. Secondary outcome measures were 180-day
mortality, length of stay and hospital readmission. The
stepped-wedge design allows hospitals to function as
their own controls, with roughly half of the 16,000 re-
cruited patients treated before the QI intervention, and
half in hospitals activated to the intervention. The main
analysis in the EPOCH trial showed no improvements in
any of the primary or secondary outcomes [7].
Process evaluation and ethnographic findings
Fifteen geographic clusters underwent randomisation
including 97 NHS hospitals. Four hospitals withdrew
before the start of the trial, leaving 93 participating.
Programme activity data, as defined in Table 3, were avail-
able for all hospitals. Eighty-three percent (77/93) of QI
leads completed the exit questionnaire. In 17/77 (22%)
questionnaire returns, two or more professionals submitted
a joint response. In the remainder of returns, responses
were from a single QI lead. All but four responses (73/77)
were from, or included input from, QI leads from the disci-
plines of anaesthesia or critical care. In comparison, 17/77
(22%) of responses included surgical input and 6/77 (8%)
included nurse input. Across all six sites in the ethno-
graphic sub-study, a total of 54 interviews were under-
taken, with over 200 h of observation. The evaluation
results are structured using the following framework: deliv-
ery of the intervention at the cluster level, response to the
intervention at the cluster level, delivery of the intervention
at the site level and the response to the intervention by
individuals targeted (the EPOCH QI leads) [24].
Delivery of the intervention at the cluster level
A total of 15 face-to-face, 1 day, cluster activation meetings
(including QI training), planned to coincide with clusteractivation, and 15 follow-up meetings (one for each geo-
graphical cluster) were held as part of the QI programme.
Figure 2 summarises the EPOCH QI programme ‘as
planned’ and ‘as delivered’; the major change to the plan
was the addition of follow-up cluster meetings at 12–
16 weeks post-activation to the intervention. Aside from
local QI leads (surgeons, anaesthetists and critical care
physicians), research nurses, theatre nurses and trainees in
surgery and anaesthesia were the most common groups to
participate in the activation meetings. The number of
participants from each hospital at the follow-up cluster
meeting was substantially fewer than at the first meeting.
Figure 3 displays the numbers of QI leads attending the
meetings from each hospital. The median number of par-
ticipants (both QI leads and other invited colleagues) at
the activation meetings and follow-up meetings were three
per hospital (range 0–19) and one per hospital (range 0–8)
respectively. The web-based resources were housed within
a Virtual Learning Environment (VLE) which contained a
total of 66 pages or resources, to be viewed online or
downloaded, at the commencement of the programme, in-
creasing to 84 pages or resources by the end of the study.
The site could only be accessed by registered EPOCH trial
local QI team members. In total, 16,120 ‘hits’ (visits to the
site, page view and resource views or downloads) were
logged over the course of the trial period. The median
number of Virtual Learning Environment hits per hospital
was 136 (min 11, max 519; IQR = 123). The number of
users per hospital ranged from one to seven with a median
of three users.
Response to the intervention at the cluster level
Themes derived from responses to a free-text question in
the exit questionnaire about the improvement programme
are described in Table 4. Findings from the ethnographic
evaluation mirror the themes described in Table 4, indicat-
ing that participants had a positive perception of the
EPOCH cluster activation meetings, as well as the
12-week follow-up meetings. They felt that the EPOCH
QI team demonstrated the relevance of the project and
felt energised by the meetings. They also reflected posi-
tively on the practical nature of the meetings, the oppor-
tunity to share ideas and learn from others and the utility
of the web-based resources and tools to analyse NELA
data. Analysis of the ethnographic data indicated that
buy-in from QI leads was often already high and many
had achieved local improvements relevant to EPOCH’s
mission long before the activation meetings. Nonetheless,
even for those individuals, the activation meeting was an
important place for learning and sharing experiences. It
was important for local enthusiasts to see that they ‘were
not alone’ in struggling to improve peri-operative care and
learn how other sites managed to change aspects of care.
However, themes derived from the questionnaire data
Fig. 2 The EPOCH trial quality improvement programme. Legend: QI, quality improvement; PDSA, Plan-Do-Study-Act cycles, a specific approach
to QI; NELA, National Emergency Laparotomy Audit; NHS, National Health Service
Fig. 3 QI lead attendance at QI programme meetings
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Table 4 Common themes identified from feedback regarding the Quality Improvement (QI) programme
“What was most helpful about the QI programme”
(from 56 free-text responses)
“What could have been better about the QI programme”
(from 36 free-text responses)
QI training (at the meetings) and online resources (n = 14) More clarity about the intervention and how to implement it (n = 10)
Networking with colleagues from other hospitals (facilitated by meetings)
(n = 11)
More meetings, and more input from the central team (n = 8)
Good communication and support (n = 12) Better support / better run-chart tool (n = 7)
The Excel tool to generate run-charts from National Emergency
Laparotomy Audit (NELA) data (n = 11)
A longer intervention period for those activated late (due to the stepped
wedge trial design) (n = 7)
Enthusiasm and motivation generated by the EPOCH team and project
overall (n = 8)
Less components in the clinical pathway (n = 4)
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mixed, in particular the run charts to support data analysis
and visualisation and the guidance on how to improve
care in line with care pathway.
Delivery of the intervention at the site level
The clinical intervention was a 37-component care path-
way (see Fig. 1). Questionnaire data showed that only 11
care processes were the focus of improvement efforts inFig. 4 Clinical processes focussed on by hospital teams during EPOCH. Legen
VTE, venous thrombo-embolism> 50% of responding hospitals; the remaining pathway
components had more variable uptake (see Fig. 4 and Seg-
mentation section below). The QI intervention comprised
six strategies (see Tables 1 and 2). Questionnaire data
showed that 10/77 (13%) of QI leads responding said that
all six strategies had been used, 23/77 (30%) indicated five
had been used, 21/77 (27%) indicated four had been used,
8/77 (10%) used three strategies, 10/77 (13%) used two
and 5/77 (6%) just one. No QI lead reported zero qualityd: CT, computer-aided tomography; WHO, World Health Organization;
Table 5 Reported usage of each quality improvement (QI) strategy
Question related to QI strategy usage Response (n = variable)
PDSA approach
Did you or your colleagues use the ‘Plan Do Study Act’ (PDSA) cycle approach
during your QI activities?
• 61% (45/74): Yes, sometimes
• 5% (4/74): Yes, often
• 34% (25/74): No
QI team formation
At your site, was a formal team created to work on QI activities related to EPOCH?
Definition of QI Team:
A group of individuals that work together on the QI project. The team is defined by
their shared goals and mutual accountability for the QI
• 60% (46/77): Yes
• 27% (21/77): No
• 13% (10/77): Other (comments indicated informal teams
often existed)
Data collection and analysis
After starting EPOCH did you or your colleagues download and analyse your local
NELA data?
If yes, how frequently did you do this?
If yes, did you use run-charts?
Were systems set up to collect National Emergency Laparotomy Audit (NELA)
data prospectively?
• 79% (61/77): Yes
• 21% (16/77): No
• 43% (26/61): Analysing data monthly or bi-monthly
• 57% (35/61): Analysing data less frequently
• 92% (56/61): Used run-charts to analyse data
• 51% (38/74): Yes
• 49% (36/74): No
Stakeholder meeting
Did you hold a stakeholder meeting as one of your QI activities? For example,
a meeting for all professionals involved in patient care
• 55% (41/75): Yes
• 45% (34/75): No
Pathway segmentation
Please indicate the statement that most closely fits your hospitals improvement
or implementation activity during EPOCH
• 22% (17/77): We introduced a single pathway of care
(across pre-, intra- and post-operative phases)
• 32% (25/77): We introduced separate pathways or care
bundles for the peri-op phases
• 40% (31/77): We focused on introducing individual/separate
interventions
• 5% (4/77): Other
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usage of each QI strategy. Below, questionnaire and
ethnographic data are combined to elaborate on the usage
of each of these strategies and the effects of these on care
pathway implementation.
Use of Plan-Do-Study-Act
At activation meetings, the use of PDSA cycles was pre-
sented to participating teams explicitly as a model for
experimentation and the planning of change, with
instructions and supporting tools for putting it into
practice. The data in Table 5 indicates this approach was
used, but perhaps not in the regular, methodical man-
ner recommended. The ethnographic findings also
indicated that no site applied the formal PDSA meth-
odology ‘by the book’. However, this did not mean
sites failed to engage in creative experimentation. In-
stead, sites adopted a less formal planning approach,
which included the general tenets of trying out small
tests, reviewing and making further change, but typic-
ally excluding the setting of numerical goals against
which to measure progress:
The only thing is we are not being particularly good
at is the PDSA cycle but then again […] Well I suppose
we are. We are just not doing it formally […] I have
carried on and done it in a way that works and makes
sense to me. (Intensive Care Consultant, Site 6)Team approach
At the activation meetings, QI leads were strongly
advised to recruit a formal team of ‘willing’ inter-
professional colleagues to work with them on local im-
provement activities. The data in Table 5 indicate that
just under two thirds of sites had a formal team to work
on this major project. All sites had committed to an
inter-professional team approach by formally nominating
representatives from surgery, anaesthesia and critical
care; for those who managed to recruit others to their
team, the benefits were apparent:
I mean the really important thing was that we had a
group, from our point of view, I’ve got an engaged
surgeon who I work with, and I’ve got some good junior
guys, and we’ve got plenty of people who’ve actually just
taken the ball and run with it […] So possibly we should
be involving others but the small team we have at the
moment has been quite productive and we seem to be
hitting most of the QI targets with the team we have
got. (Intensive Care Consultant, Site 5)
However, only three of the six sites included in the
ethnographic work maintained surgical leadership
throughout the intervention period; in two sites,
surgical involvement in the QI team decreased after
activation, and in the other site surgical involvement
did not become apparent until later on.
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lead was seen as a disadvantage to wider surgical in-
volvement with the improvement work (see also the
‘Engagement’ section below):
It started as an anaesthetic project basically but it is
really a surgery thing. […] Looking back I wish we took
advantage of [having an engaged surgical lead] right at
the beginning. I think we would have got more
involvement with the surgeons which is obvious
because they are the thing that runs right through it all.
(Research Nurse, Site 1)Use of data feedback and run-charts
At the activation meetings, use of NELA data as a driver for
engaging colleagues and monitoring improvement was
promoted and tools designed for the EPOCH project were
provided to do this. The data in Table 5 show that most,
but not all, teams analysed their NELA data occasionally,
but far fewer were doing this on a regular (monthly/bi-
monthly) basis. Many sites reported challenges in simply
collecting the data; only half of questionnaire respondents
indicated that systems had been set up by the end of the
EPOCH study to collect NELA audit data prospectively. For
the other half of respondents, it was reported data collection
usually involved the NELA lead (often also an EPOCH QI
lead) collecting and entering data retrospectively:
We need to look at the recent outcome of the NELA.
But we haven’t, because we were concentrating on
NELA [data collection] and less on the EPOCH
care pathway, we haven’t been able to monitor that
unfortunately. (Research Nurse, Site 1)
The ethnographic findings indicated that all six sites
tried hard to collect and use data in their improvement ef-
forts. However, this was undertaken more consistently in
three of the six sites. During the implementation process,
the EPOCH teams that seemed more successful with data
collection were also those that appeared to have achieved
stronger engagement with colleagues (see ‘Engagement’
section below). This perhaps reflects the challenges of
collecting the large NELA data set before any analysis, or
improvement activities based upon it, could occur:
Well there is a nominal person in charge [of the NELA
audit] but in terms of actual, the whole thing is devolved
back round to the anaesthetic department. Well we try
and get everything done, as far as possible, doing it in
the operating theatre to engage the surgeons, as part of
that process. Even if they only do data entry on one page,
or even if we only discuss it, and one of us will do the
data entry. (Intensive Care Consultant, Site 3)Engagement
At 5 weeks before activation to the intervention, sites
were contacted and asked to start planning a stakeholder
meeting, to coincide with activation and to engage rele-
vant colleagues with the aims of the trial intervention
and the required improvements. Just over half the re-
spondents indicated they had held such a meeting (see
Table 5). Of the 71 QI leads who responded to a ques-
tion about senior support during the trial, only 15 (21%)
described active executive board support for the quality
improvement work related to EPOCH (e.g. funding staff
time to support the project or making the project a
board-level quality and safety priority). The ethnographic
study allowed observation of the ongoing engagement ac-
tivities that occurred beyond the initial EPOCH meetings.
When local teams drew on wider connections, this ap-
peared to work to their advantage, pulling in contacts in
management, other disciplines such as radiology, and clini-
cians and administrators with responsibilities relevant to
the pathway, for example sepsis identification and treat-
ment. The ability to engage colleagues successfully, and en-
courage active involvement in improvement efforts, seemed
to depend to a large extent on existing relationships:
I think, you know, we’re fairly cohesive, we have a
cohesive department, and we’re not perfect, but we
do. We don’t have any personality clashes that get in
the way of this at the moment…We’ve had no problem
with the surgical engagement and have had no problem
with the anaesthetic engagement either. (Intensive Care
Consultant, Site 5)
Even in sites where engagement per se was not seen to
be a problem, the simple factor of the time required to
have the required discussions with colleagues was raised
as an issue:
I think a longer period of time would have helped
because most of these changes are by default, sort of
long term changes, but also there is a lot of discussion
involved with them all and getting a lot of people to
agree and of course each of those conversations,
despite the fact that you think it is going to be quick,
ends up going back to someone else and then a week
passes and another week passes and before you know
it a month and a half has gone and you have finally
got to the conversation you wanted to have in the first
place. (Consultant Anaesthetist, Site 6)Segmenting the pathway and decisions about the clinical
pathway components
At the activation meeting, QI leads were advised to con-
sider segmenting the proposed pathway to make the
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was offered regarding selecting which elements of the
pathway to work on first and how to plan a step-wise im-
plementation of the pathway that would work in their
local context. However, by the end of the intervention
period, only a fifth of questionnaire respondents (17/77)
said that they had attempted full pathway intervention. Of
the potential 37 pathway components, there were 11 inter-
ventions which > 50% of respondents said had been the
focus of improvement efforts (Fig. 4). Eight of these 11
processes were also those captured by NELA and were the
same as the main EPOCH trial process measures.
The ethnographic analysis suggests that agreement on
the need for a pathway for this patient group was strong
amongst QI leads and colleagues. Implementation chal-
lenges were predicted however which shaped decisions
about the initial focus for improvement. These decisions
were made as pragmatic choices, based on a tension
between what was felt to be most important to improve
versus what was manageable within work constraints:
…the surgeons and the anaesthetists and [the PI], they
picked what they thought would be their top ten [from
the EPOCH pathway] that we would want to institute
because we thought if we tried to introduce all 30 in one
go, the resistance that we would be up against would be
quite difficult […] so we picked what we thought were
the most important ones (Surgical Trainee, Site 4)
The idea of a step-wise approach resonated with
teams, with the hope that initial success would pave the
way for further pathway components to be addressed:
The ideal that we are aiming for would be to have all
of the 37 (pathway) points done consistently for
everybody…although the way that I think we have
approached it is to cater for the ones that are perhaps
easier to understand and implement…then on the
back of those introduce the rest of them.
(Anaesthetic SHO, Site 1)
Some other decisions came down to components of
the pathway being seen as having more marginal benefits
by some QI leads:
I think there were some bits that we talked about
before about the inter-operative delivery so things like
how you ventilate people and things like that that we
didn’t necessarily want to have the argument about
[…] we might cross that bridge later but that wasn’t
one of our first aims (Consultant Anaesthetist, Site 6)
As mentioned above, where teams did not include all
clinical leads in equal leadership roles, decisions aboutwhich processes to improve often depended on which
discipline was most active in the EPOCH team.
This step-wise, segmentation approach was not univer-
sally adopted however:
[The] endpoint is reduced mortality and reduced
morbidity for emergency laparotomy patients. My
view would be, look, we really don’t know, just do the
whole bloomin’ lot and then see what happens.
(Consultant Surgeon, Site 2)
In this site, their main implementation tool was thus
an extensive checklist which brought the EPOCH path-
way together. But by the end of the trial, they were still
discussing the need to ‘implement the checklist’; pro-
gress had not been as rapid as they had hoped.
Response to the intervention by QI leads: reflections on
the change process
QI leads reflected on: ‘what would you continue
doing?’ and ‘what would you do differently if you
were to do EPOCH again?’. 96% (74/77) of
respondents left a total of 299 comments. Eighteen
themes were generated for each question (36 in total)
and these were further grouped into nine high-level
themes (Table 6). Key themes (in terms of quantity
and content of responses) include the importance of
engaging colleagues (Theme 2) and some of the
challenges involved in this, particularly in relation to
surgical, wider inter-professional, and trainee
involvement (Theme 6), and identification of robust
data-collection and analysis in underpinning change
(Theme 1)—and the need for more training and
capacity to analyse and utilise data effectively
(Theme 7). Other themes also suggest that respondents
felt that much of the approach advocated by EPOCH
would work (Themes 3-5), but with important
challenges around capacity and persuading
colleagues—whether gently or more coercively—of
the need to contribute to change (Themes 8-9).Context
Limited resources, both human and financial, and organ-
isational upheaval were often mentioned, in particular in
Ethnographic Site 3, although it is likely that this experi-
ence was shared by a significant subset of the 93 hospi-
tals in the trial. Across almost half the trial sites, a lack
of organisational support for data collection was noted.
The challenges this posed for QI leads must not be
underestimated, with the burden of collecting data (for
NELA and ostensibly for use as part of the EPOCH im-
provement work) may have overwhelmed many. As
Table 6 Themes emerging from QI leads reflections on leading improvement
High-level themes Sub-themes (number of supporting comments)
What QI leads would continue doing
1. Keep working on data collection and feedback Providing feedback on performance, incl. data feedback (30)
Use run-charts (19)
Good data collection process/data collection support (14)
Using data to create situational awareness (4)
2. Keep working on engagement, involvement and collaboration Engage/involve all relevant stakeholders (22)
Interprofessional involvement (9)
Form a QI team (8)
Engage/involve trainees (4)
Identify enthusiastic colleagues (4)
Collaborate with other hospitals (2)
Obtain senior support for the project (2)
3. Using a ‘systems thinking’ approach to improvement Hardwire changes into system (9)
Building risk scoring into care pathway (8)
Use a checklist/care bundle approach (2)
4. Specific clinical interventions Clinical interventions (9)
Risk stratification (6)
5. Use an iterative approach to change Take an incremental/stepped approach to improvement (6)
Persist with implementation (2)
What QI leads would do differently
6. Engage and involve people more effectively Wider engagement of stakeholders (17)
More surgical engagement/involvement in project (15)
More interprofessional involvement (10)
Better engagement/involvement of trainees (6)
Form a larger QI team (5|
Involve more people (3)
7. Get data collection and feedback right Improve data collection/more data support (17)
More data feedback (8)
More data analysis (4)
8. Obtain stronger senior support for the project Stronger senior leadership/board level support (16)
More protected time for the project (7)
9. Work on own leadership/ project management skills Manage the QI team more effectively (10)
Get started sooner (6)
Be more forceful (3)
Focus on motivation/behaviour change (2)
Use an iterative approach (2)
More collaboration with other hospitals (2)
Better planning of improvements / system changes (2)
QI quality improvement; Run-chart a specific type of time-series chart used in quality improvement
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struggled to find time:
Again, it’s finding the time to do all this stuff…the
trust hasn’t given anyone any time for this, so people
are doing it, you know, because they want to. So, you
know, it would help if it had time funded time for it,
but you know that’s never going to happen in the
NHS […] not at the moment. (Intensive Care
Consultant, Site 5).Discussion
The principal finding of this process evaluation was that
the QI programme delivered the QI skills training and re-
sources as intended, the programme was generally wellreceived by QI leads and there was an overall sense of mo-
tivation to address the challenge of high-mortality for this
patient group. Local adaptation to both the QI and clinical
interventions was actively encouraged, but the extent of
variability and adaptation in the implementation process
was greater than anticipated. There were only 11 clinical
interventions which more than half of teams attempted to
improve from the clinical pathway (the ‘hard core’ of the
intervention) and only half of the trial cohort reported
using five or all six of the QI strategies (the ‘soft periphery’
of the intervention) designed to enable pathway imple-
mentation [16]. Ethnographic findings indicated that QI
leads predicted, and often experienced, multiple and often
significant challenges as they attempted to lead change in
their hospitals, which shaped which components of the
pathway they chose to focus on first and how they
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no effect of the intervention on patient outcomes or care
processes [7]. Our experience during the QI programme
(meeting teams, reviewing their data) suggests that some
hospitals were able to make modest, and sometimes
substantial, improvements in care processes but the main
trial analysis was not designed to provide this level of
granularity.
When testing clinical interventions within a clinical
trial, it is important to make the distinction between the
design of the intervention and the operational elements re-
quired for effective delivery [31]. Our process evaluation,
discussed in this paper, adds to the main trial findings by
providing insight into the challenges at both the design (or
programme) level and the hospital (operational) level. At
the design level, adaptability is often essential in ensuring
that quality improvement interventions can fit within differ-
ent contexts, and this was built into the EPOCH interven-
tion. However, fidelity to key parts of an intervention is also
important to maximise the likelihood of success [32]. In this
case, it may have been that an intervention design that
focussed on a smaller number of strategies might have
achieved greater fidelity and, therefore, greater impact on
patient outcomes. This may be especially relevant given that
data from both the ethnography and the exit questionnaire
suggest that, at the operational level, QI leads faced many
local challenges including lack of engagement of colleagues
and hospital executives. Even in sites where such challenges
were minimal, QI leads were making choices about which
clinical components of the pathway to focus on first, in rec-
ognition that implementing the entire pathway may be be-
yond the limited time and resources they had. Thus, the
extent of the task required, combined in many sites with or-
ganisational challenges, may have meant that many teams
simply ran out of time to implement the pathway within
the intervention period. Earlier, smaller, studies have shown
that marked improvement may take time and can continue
after the intervention period [14]. Data was also an oper-
ational challenge for many. NELA had only commenced
4 months before the start of the trial; 20 months after the
launch of NELA, at the end of this study, only half of hospi-
tals reported having prospective data collection systems in
place. It is likely therefore that many QI leads were focussed
on collecting and in-putting data to the detriment of other
improvement activity. A key theme from the reflections of
QI leads was that they would have liked to have had better
mechanisms not only for data collection but also for data
feedback. Whilst data is central to any quality improvement
project, it is the use of this data through feedback, com-
bined with other improvement strategies, that is likely to
achieve more robust results [19, 33–35]. If future QI pro-
grammes are to capitalise on concurrent national audits or
other ongoing data collection, the timings need to be con-
sidered to allow embedding of data collection processesbefore the start of the improvement work which may take
considerably longer than anticipated [33].
There are other explanations for our failure to change
the primary outcome metrics. It is possible that our
programme theory was incorrect, and there was only a
weak causal link between the interventions and ultimate
outcomes. This seems unlikely given the evidence base for
the clinical and quality improvement interventions. The
EPOCH trial intervention ran at a time of significant
change in the British NHS, including major system re-
organisation and considerable fiscal instability for many
hospitals [36]. These changes may have impacted on staff
morale and on the ability of clinicians to engage with and
focus on their local projects [37]. Another conclusion that
might reasonably be drawn from our evaluation is that the
EPOCH trial intervention was too ambitious. Even where
QI leads developed the capabilities to enable change (e.g.
through use of the QI strategies), they were asked to lead
that change in addition to their regular clinical commit-
ments and may not have had the capacity, in terms of
time, resources and other personnel, to do so. The social
aspects of improvement are as likely to be as important as
more technical aspects, such as data analysis and feedback,
but QI leads used the social QI strategies less than those
related to data. Building and maintaining effective social
relationships is time-consuming and challenging, and the
uptake of ‘non-technical’ and ‘socio-adaptive’ interventions
can be low amongst health professionals [18]. However, a
key reflection of QI leads was that they would have liked
to spend more time engaging and involving colleagues.
We would suggest therefore more emphasis and training
in socio-adaptive interventions should be built into future
programmes together with a recognition that dedicated
time is required to support frontline staff in prioritising
such interventions [38, 39]. Some leads reflected on their
difficulties in engaging with senior or executive-level col-
leagues, and only a fifth of respondents indicated they re-
ceived active support from their board. Effective quality
improvement requires a reciprocal relationship between
the employee and the organisation, and lack of organisa-
tional support is likely to have been an important barrier
to improvement [40, 41]. This is an important lesson; if
the goodwill and motivation of frontline staff is to be
mobilised for improvement work, then adequate time and
support in the workplace plus training is required to give
these professional the best chance of success. This has
ramifications for those designing future programmes, se-
nior management and national-level policy makers.
In relation to the delivery of the programme, the time
available to coach teams was limited in comparison with
other reported quality improvement interventions, such
as the Institute for Healthcare Improvement Break-
through Series Collaborative model [42]. Our training
programme was designed as a parsimonious
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it might be adapted and replicated widely if proven
successful. A higher intensity programme might have led
to greater intervention fidelity, although recent evidence
suggests that this may not always be the case [43,
44]. EPOCH may have suffered from the lack of a
pilot trial and perhaps future similar interventions
should be piloted first [45], or use a cluster trial de-
sign that allows for iterative intervention development
within the trial period to enable ongoing intervention
optimisation [46].
A major strength of this study is that it provides a full, de-
tailed description of how a large-scale trial of a complex
intervention was designed, delivered and received, at over
half the hospitals in the UK NHS. Following calls for better
intervention reporting, we hope we have provided insights
into possible reasons why ultimately the trial was unsuc-
cessful and learning for future studies of this nature [23,
47]. The evaluation was conducted by researchers both in-
side and outside the main trial team, offering both detailed,
nuanced knowledge of the trial, with an external perspec-
tive; all data collection and analysis were completed before
the trial results were known. This study also has several
limitations. The process evaluation relied in part on
self-reported data, often collected from a single representa-
tive of each hospital. A response rate of 83% suggests that
our data were largely representative of the entire EPOCH
trial cohort. However, because non-responders may have
had different experiences with the EPOCH programme, it
is possible that some relevant factors may be missing.
Self-reported data may be subject to both recall and/or so-
cial desirability bias. To minimise recall bias, we started col-
lecting data within a month of the completion of the trial.
Whilst we cannot quantify the magnitude of potential social
desirability bias, many respondents reported both positive
and negative experiences and many reported not using sev-
eral of the quality improvement strategies. Responses
tended to be relatively brief, with no possibility for respon-
dents to elaborate on interesting or unclear statements.
Thus, we found these data to be a useful adjunct to, but no
substitute for, the more extensive qualitative insights pro-
vided by the ethnographic study.Conclusion
Programmes designed to support clinician-led improve-
ment may need to focus on both developing the necessary
QI capabilities whilst also advocating (or even mandating)
clear organisational support for these professionals to lead
change. Additional capacity, including job-planned time
to engage stakeholders plus data support and/or adequate
date collection mechanisms, are likely pre-requisites for
the successful delivery of complex interventions, such as
implementing a care pathway for emergency surgery.Additional file
Additional file 1: Full details of the EPOCH Quality Improvement
Programme. (PDF 1223 kb)
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